Industry: Pharmaceuticals, Biotechnology
Arteriocyte is a clinical stage research and development biotechnology company based in Cleveland, Ohio that is developing proprietary, adult stem cell-based therapies for the treatment of ischemic diseases or where ischemia is the underlying culprit in the progression of that disease. These diseases include coronary artery disease, peripheral vascular disease, vascular complications of diabetes and neurodegenerative conditions that are exacerbated because of poor blood flow. The Company’s first clinical therapeutic (ACY001) entered human safety evaluation in the US in 2006 for the treatment of chronic coronary ischemia. ( www.arteriocyte.com )
Arteriocyte , Inc.
11000 Cedar Avenue
Cleveland, Ohio 44106
USA
Tel: (216) 658-3970
Fax: (216) 229-7323